Similar and mimics: Latin America biosimilar regulations

Int J Rheum Dis. 2019 Jan;22(1):6-8. doi: 10.1111/1756-185X.13461.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Biological Products / adverse effects
  • Biological Products / pharmacokinetics
  • Biological Products / therapeutic use*
  • Biosimilar Pharmaceuticals / adverse effects
  • Biosimilar Pharmaceuticals / pharmacokinetics
  • Biosimilar Pharmaceuticals / therapeutic use*
  • Drug Approval / legislation & jurisprudence*
  • Drug Development / legislation & jurisprudence*
  • Government Regulation
  • Humans
  • Latin America
  • Mexico
  • Patient Safety / legislation & jurisprudence
  • Policy Making
  • Risk Assessment
  • Risk Factors

Substances

  • Biological Products
  • Biosimilar Pharmaceuticals